FR2429214A1 - Composes et compositions cytostatiques hypotenseurs et analgesiques et procedes de preparation - Google Patents
Composes et compositions cytostatiques hypotenseurs et analgesiques et procedes de preparationInfo
- Publication number
- FR2429214A1 FR2429214A1 FR7915550A FR7915550A FR2429214A1 FR 2429214 A1 FR2429214 A1 FR 2429214A1 FR 7915550 A FR7915550 A FR 7915550A FR 7915550 A FR7915550 A FR 7915550A FR 2429214 A1 FR2429214 A1 FR 2429214A1
- Authority
- FR
- France
- Prior art keywords
- hypotensive
- analgesic
- compositions
- preparation
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 208000001953 Hypotension Diseases 0.000 title abstract 2
- 230000000202 analgesic effect Effects 0.000 title abstract 2
- 239000000824 cytostatic agent Substances 0.000 title abstract 2
- 230000001085 cytostatic effect Effects 0.000 title abstract 2
- 208000021822 hypotensive Diseases 0.000 title abstract 2
- 230000001077 hypotensive effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/12—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/20—Free hydroxyl or mercaptan
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91732778A | 1978-06-20 | 1978-06-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2429214A1 true FR2429214A1 (fr) | 1980-01-18 |
| FR2429214B1 FR2429214B1 (enrdf_load_stackoverflow) | 1985-03-08 |
Family
ID=25438634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7915550A Granted FR2429214A1 (fr) | 1978-06-20 | 1979-06-18 | Composes et compositions cytostatiques hypotenseurs et analgesiques et procedes de preparation |
Country Status (14)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4238500A (en) * | 1979-04-06 | 1980-12-09 | National Foundation For Cancer Research | Cyclic double hemiacetals of enediol compounds and compositions and methods for preparing and using same |
| EP0057699A4 (en) * | 1980-08-14 | 1982-11-08 | Nat Foundation For Cancer Res | 5,6-O-ISOALKYLIDENE ASCORBIC ACID DERIVATIVES. |
| TWI369379B (en) | 2007-01-26 | 2012-08-01 | Rohm & Haas | Light-scattering compositions |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2126269A1 (enrdf_load_stackoverflow) * | 1971-02-24 | 1972-10-06 | Basf Ag | |
| FR2190817A1 (enrdf_load_stackoverflow) * | 1972-07-01 | 1974-02-01 | Basf Ag | |
| DE2514001A1 (de) * | 1975-03-29 | 1976-10-07 | Basf Ag | Verfahren zur herstellung von glyoxalmonoacetalen |
-
1979
- 1979-05-30 NL NL7904249A patent/NL7904249A/xx not_active Application Discontinuation
- 1979-06-01 AU AU47689/79A patent/AU521500B2/en not_active Ceased
- 1979-06-05 CA CA000329092A patent/CA1142948A/en not_active Expired
- 1979-06-15 DE DE19792924077 patent/DE2924077A1/de active Granted
- 1979-06-18 SE SE7905330A patent/SE445643B/sv not_active IP Right Cessation
- 1979-06-18 FR FR7915550A patent/FR2429214A1/fr active Granted
- 1979-06-19 DK DK256679A patent/DK160828C/da not_active IP Right Cessation
- 1979-06-19 NO NO792040A patent/NO154966C/no unknown
- 1979-06-19 HU HU79NA1138A patent/HU177875B/hu not_active IP Right Cessation
- 1979-06-20 JP JP7796679A patent/JPS5513274A/ja active Granted
- 1979-06-20 CH CH575679A patent/CH641454A5/de not_active IP Right Cessation
- 1979-06-20 IT IT23721/79A patent/IT1121294B/it active
- 1979-06-20 GB GB7921468A patent/GB2028309B/en not_active Expired
- 1979-08-08 IE IE1220/79A patent/IE48434B1/en not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2126269A1 (enrdf_load_stackoverflow) * | 1971-02-24 | 1972-10-06 | Basf Ag | |
| FR2190817A1 (enrdf_load_stackoverflow) * | 1972-07-01 | 1974-02-01 | Basf Ag | |
| DE2514001A1 (de) * | 1975-03-29 | 1976-10-07 | Basf Ag | Verfahren zur herstellung von glyoxalmonoacetalen |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2028309B (en) | 1982-08-04 |
| DK160828C (da) | 1991-10-14 |
| SE445643B (sv) | 1986-07-07 |
| DE2924077C2 (enrdf_load_stackoverflow) | 1990-08-16 |
| NO154966B (no) | 1986-10-13 |
| NL7904249A (nl) | 1979-12-27 |
| FR2429214B1 (enrdf_load_stackoverflow) | 1985-03-08 |
| CH641454A5 (de) | 1984-02-29 |
| SE7905330L (sv) | 1979-12-21 |
| NO154966C (no) | 1987-01-21 |
| DE2924077A1 (de) | 1980-01-17 |
| JPS6410515B2 (enrdf_load_stackoverflow) | 1989-02-22 |
| IE48434B1 (en) | 1985-01-23 |
| HU177875B (en) | 1982-01-28 |
| DK160828B (da) | 1991-04-22 |
| GB2028309A (en) | 1980-03-05 |
| IT1121294B (it) | 1986-04-02 |
| IT7923721A0 (it) | 1979-06-20 |
| JPS5513274A (en) | 1980-01-30 |
| CA1142948A (en) | 1983-03-15 |
| AU4768979A (en) | 1980-01-03 |
| DK256679A (da) | 1979-12-21 |
| AU521500B2 (en) | 1982-04-08 |
| NO792040L (no) | 1979-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2446822A1 (fr) | 6-oxodecahydroquinoleines | |
| FR2430412A1 (fr) | Derives substitues de propanolamine utiles comme medicaments et procede de leur preparation | |
| FR2367741A1 (fr) | Nouveaux mercaptoacylamino-acides | |
| FR2372219A1 (fr) | Compositions anti-solaires | |
| JPS5432460A (en) | Cycloalkylidenemethylphenylacetic acid derivative and their preparation | |
| FR2430418A1 (fr) | Derives halogenomethyles d'a-aminoacides, leur preparation et leurs utilisations therapeutiques | |
| FR2434802A1 (fr) | Oxime-carbamates et carbonates utiles pour la protection des cultures | |
| FR2358382A1 (fr) | Nouveaux nonapeptides, leurs procedes de preparation et compositions pharmaceutiques les contenant | |
| FR2383185A1 (enrdf_load_stackoverflow) | ||
| FR2445330A1 (fr) | Derives du 11-bromo-14,15-dioxo-e-homo-eburnane leur preparation et leur utilisation comme medicament | |
| FR2445318A1 (fr) | Procede de preparation de 1-(3-mercapto-propanoyl)-l-prolines | |
| FR2384745A1 (fr) | Derives de la somatostatine et leur preparation | |
| FR2405942A1 (fr) | Procede d'obtention du 3-oxa-tricyclo (6.2.1.02,7) undecane-4-one et son utilisation a titre d'agent parfumant | |
| FR2429214A1 (fr) | Composes et compositions cytostatiques hypotenseurs et analgesiques et procedes de preparation | |
| FR2421179A1 (fr) | 3-0-(b-d-glucuronopyrannosyl)-soyasapogenol b, sa preparation et ses utilisations therapeutiques | |
| FR2361352A1 (fr) | Derives acylamino (alkyl)-benzeniques, leur procede de preparation et leur application | |
| FR2361351A1 (fr) | Intermediaires de preparation d'homologues de somatostatine | |
| FR2442226A1 (fr) | Anilines substituees, leur preparation et leurs utilisations | |
| FR2381035A1 (fr) | Urees substituees utiles comme medicaments et procedes pour leur preparation | |
| FR2357558A1 (fr) | 2,6-methano-2h-1-benzoxocines | |
| FR2387215A1 (fr) | 4-alcoylthio-2-trifluoromethylalcanesulfonanilides et leurs derives | |
| FR2404001A1 (fr) | Derives d'oxazolidone-2 utiles comme medicaments et procedes pour leur preparation | |
| FR2434806A1 (fr) | 1-(2,6-dihalobenzoyl)-3-(2-pyridinyl-5-substitue) urees, leur preparation et leur utilisation comme insecticides | |
| FR2381030A1 (fr) | Phenylaminomethyl-2 imidazolines et leur preparation | |
| FR2446841A1 (fr) | Procede de preparation de 1a,3b-dihydroxy-d5-steroides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |